UPDATE – Myriad Genetics to Present at 43rd Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Myriad Genetics (NASDAQ: MYGN) has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco. The company's President and CEO Paul J. Diaz, along with COO Sam Raha, will deliver a presentation on Wednesday, January 15, at 3:45 PM PT (6:45 PM ET).

Investors and interested parties can access the presentation through a live webcast available in the investor relations section of Myriad's website at investor.myriad.com. An archived version of the presentation will be made available following the live event.

News release updated to include the members of the management team speaking at the conference.

SALT LAKE CITY, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced Paul J. Diaz, President and CEO, and Sam Raha, COO, will present at the 43^rd Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, Jan. 15, at 3:45pm PT (6:45pm ET).

The presentation will be available through a live webcast in the investor relations section of Myriad’s website at investor.myriad.com. An archived edition of the presentation will be available later that day.

About Myriad Genetics
Myriad Genetics is a leading genetic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs. For more information, visit www.myriad.com.

Investor Contact
Matt Scalo
(801) 584-3532
IR@myriad.com

Media Contact
Glenn Farrell
(385) 318-3718
PR@myriad.com

FAQ

When is Myriad Genetics (MYGN) presenting at the 2025 J.P. Morgan Healthcare Conference?

Myriad Genetics will present on Wednesday, January 15, 2025, at 3:45 PM PT (6:45 PM ET).

How can investors watch Myriad Genetics' (MYGN) J.P. Morgan Healthcare Conference presentation?

Investors can watch the presentation through a live webcast available in the investor relations section of Myriad's website at investor.myriad.com. An archived version will also be available after the event.

Who will represent Myriad Genetics (MYGN) at the 2025 J.P. Morgan Healthcare Conference?

Paul J. Diaz, President and CEO, and Sam Raha, COO, will represent Myriad Genetics at the conference.

Where is the 2025 J.P. Morgan Healthcare Conference being held for MYGN's presentation?

The conference is being held in San Francisco.